Citations

Showing 10 of 107966 citations.

HE4 (WFDC2) Promotes Tumor Growth in Endometrial Cancer Cell Lines
Li, Jinping , Mariani, Andrea , Chen, Dong , Klatt, Edward, Podratz, Karl C. , Drapkin, Ronny , Broaddus, Russell R. , Dowdy, Sean C. , Jiang, Shi‐Wen , Chen, Hai-Bin , Chen, Haibin , Klatt, Edward, Chen, Dong , Drapkin, Ronny

Mayo Clinic

International Journal of Molecular Sciences | March 15, 2013 | Volume: 14 | Issue: 3 | Pages: 6026-6043

10.3390/ijms14036026 | PMID 23502467 Get It

HE4, also known as WFDC2, is a useful biomarker for ovarian cancer when either used alone or in combination with CA125. HE4 is also overexpressed in endometrial cancer (EC), but its function in cancer cells is not clear. In this study, we investigate the role of HE4 in EC progression. An HE4-overexpression system was established by cloning the HE4 prototypic mRNA variant (HE4-V0) into a eukaryotic expression vector. Following transfection, stable clones in two EC cell lines were selected. The effects of HE4 overexpression on cell growth and function were measured with the use of cell proliferation assay, matrigel invasion, and soft agar gel colony formation assays. HE4-induced cancer cell proliferation in vivo was examined in a mouse xenograft model. HE4 overexpression significantly enhanced EC cell proliferation, matrigel invasion, and colony formation in soft agar. Moreover, HE4 overexpression promoted tumor growth in the mouse xenograft model. HE4 overexpression enhanced several malignant phenotypes in cell culture and in a mouse model. These results are consistent with our previous observation that high levels of serum HE4 closely correlate with the stage, myometrial invasion and tumor size in patients with EC. This study provides evidence that HE4 overexpression directly impacts tumor progression in endometrial cancer.
Natriuretic Peptide Receptor-3 Gene ( NPR3 )
Pereira, Naveen L. , Pelleymounter, Linda L., Moon, Irene, Stilling, Gail A., Eckloff, Bruce W., Wieben, Eric D. , Redfield, Margaret M. , Burnett, John C. , Yee, Vivien C., Weinshilboum, Richard M. , Lin, Dong , Weinshilboum, Richard M.

Mayo Clinic

Circulation: Cardiovascular Genetics | March 15, 2013 | Volume: 6 | Issue: 2 | Pages: 201-210

10.1161/circgenetics.112.964742 | PMID 23493048 Get It

Background— The primary role of natriuretic peptide receptor-3 (NPR3) or NPR-C is in the clearance of natriuretic peptides that play an important role in modulating intravascular volume and vascular tone. Genetic variation in NPR3 has been associated with variation in blood pressure and obesity. Despite the importance of NPR3, sequence variation in the gene has not been addressed using DNA from different ethnic populations. We set out to identify and functionally characterize genetic variation in NPR3 in 3 ethnic groups. Methods and Results— DNA samples from 96 European American, 96 African American, and 96 Han Chinese American healthy subjects were used to resequence NPR3 exons, splice junctions, and flanking regions. We identified 105 polymorphisms, 50 of which were novel, including 8 nonsynonymous single-nucleotide polymorphisms, 7 were novel. Expression constructs were created for the nonsynonymous single-nucleotide polymorphisms. HEK293 cells were transfected with constructs for wild type and variant allozymes; and recombinant proteins were measured by quantitative Western blot analysis. The most significant change in NPR3 protein was observed for the Arg146 variant allozyme, with 20% of wild-type protein, primarily because of autophagy-dependent degradation. NPR3 structural modeling confirmed that the Arg146 variant protein was not compatible with wild-type conformation and could result in protein misfolding or instability. Conclusions— Multiple novel NPR3 genetic polymorphisms were identified in 3 ethnic groups. The Arg146 allozyme displayed a significant decrease in protein quantity because of degradation mediated predominantly by autophagy. This genetic variation could have a significant effect on the metabolism of natriuretic peptides with potential clinical implications.
Intratesticular kaposiform haemangioendothelioma in adults: a report of two cases
Costa, Felipe D’Almeida , Folpe, Andrew L.

Mayo Clinic

Journal of Clinical Pathology | March 15, 2013 | Volume: 66 | Issue: 7 | Pages: 623-626

10.1136/jclinpath-2013-201478 | PMID 23493478 Get It

Kaposiform haemangioendothelioma is a very rare vascular tumour of intermediate (borderline) malignancy, typically occurring in the skin and soft tissues of the extremities in infants and children. We report two morphologically and immunophenotypically classical cases occurring in the testicular parenchyma of old adults, review the literature on vascular tumours of the testis and discuss the differential diagnosis of these unusual cases.
Computational fluid dynamics simulation of an anterior communicating artery ruptured during angiography
Hodis, Simona , Uthamaraj, Susheil , Kallmes, David F. , Dragomir‐Daescu, Dan , Lanzino, Giuseppe

Mayo Clinic

Journal of NeuroInterventional Surgery | March 15, 2013 | Volume: 6 | Issue: 2 | Pages: e14-e14

10.1136/neurintsurg-2012-010596.rep | PMID 23493342 Get It

We present a computational fluid dynamics (CFD) analysis of the hemodynamic environment of an anterior communicating artery that spontaneously ruptured immediately following three-dimensional rotational angiography. Subsequent digital subtraction angiography allowed for the localization of the point of rupture within the aneurysm dome. CFD analysis demonstrated a concentrated jet that impinged directly at the site of rupture. Peak systolic pressure and wall shear stress were both maximal near the rupture location.
Long-term repair of T-cell synapse activity in a phase II trial of chemoimmunotherapy followed by lenalidomide consolidation in previously untreated chronic lymphocytic leukemia (CLL)
Ramsay, Alan G. , Leis, José F., Call, Timothy G. , LaPlant, Betsy, Bowen, Deborah A., Pettinger, Adam, Jelinek, Diane F., Hanson, Curtis A. , Shanafelt, Tait D. , Zent, Clive S. , Tun, Han W. , Kay, Neil E. , Ramsay, Alan G

Mayo Clinic

Blood | March 15, 2013 | Volume: 121 | Issue: 20 | Pages: 4137-4141

10.1182/blood-2012-12-470005 | PMID 23493782 Get It

Key Points Lenalidomide consolidation repairs T-cell immune synapses in CLL patients. Lenalidomide consolidation improved the quality of response in CLL patients treated with chemoimmunotherapy.
Tumor seeding following endoscopic ultrasonography‐guided fine‐needle aspiration of a celiac lymph node
Anderson, Bradley J. , Singh, J , Jafri, Syed F.

Mayo Clinic

Digestive Endoscopy | March 14, 2013 | Volume: 25 | Issue: 3 | Pages: 344-345

10.1111/den.12057 | PMID 23490122 Get It

“IM iD”eally treating multiple myeloma
Lacy, Martha Q.

Mayo Clinic

Blood | March 14, 2013 | Volume: 121 | Issue: 11 | Pages: 1926-1928

10.1182/blood-2013-01-476267 | PMID 23493767 Get It

Leukemic phase of ALK-positive anaplastic large cell lymphoma
He, Rong , Viswanatha, David S.

Mayo Clinic

Blood | March 14, 2013 | Volume: 121 | Issue: 11 | Pages: 1934-1934

10.1182/blood-2012-11-465369 | PMID 23610781 Get It

Faculty Opinions recommendation of Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort.
Warrington, Kenneth J.

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | March 14, 2013 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.717987130.793472404 Get It

Reversible Cerebral Vasoconstriction Syndrome
Yancy, Holly, Lee‐Iannotti, Joyce , Schwedt, Todd J. , Dodick, David W. , Schwedt, Todd J

Mayo Clinic

Headache: The Journal of Head and Face Pain | March 14, 2013 | Volume: 53 | Issue: 3 | Pages: 570-576

10.1111/head.12040 | PMID 23489219 Get It

Reversible cerebral vasoconstriction syndrome ( RCVS ) is a cerebrovascular disorder with a clinical picture that continues to be refined. It has presented to multiple subspecialties over the past several decades, bringing with it many questions regarding risk factors, diagnosis, and management. Answers have been forthcoming but many questions remain. RCVS presents with recurrent, secondary thunderclap headaches and predominantly affects young women. The mechanism of vasoconstriction is unclear, but there has been speculation regarding a hyperadrenergic state. Diagnosis requires physician awareness, vascular imaging, and knowledge of the differential. The hallmark of its diagnosis is reversibility. Management is empiric, usually with calcium‐channel blockers, as there are no controlled treatment trials for RCVS . Randomized controlled trials are needed.